Purpose Pharmaceutical technology transfer is one of the components of pharmaceutical innovation. Currently, a gap exists in pharmaceutical technology transfer from academia to industry. This study aims to develop an objective model to identify valuable pharmaceutical technologies for transferring in order to drive pharmaceutical innovation. Methods We created a support vector machine classifier model using the data of pharmaceutical patents held by universities to predict the licensing outcomes of those patents. We collected data on 369 United States (US) pharmaceutical patents, using 142 licensed patents as the positive samples and 227 unlicensed patents as the negative samples. We also collected the licensing data of the patents, and the distinguished patent features were selected for model training and generation. Upon optimization, the machine learning model was evaluated using different scoring methods. Results Our support vector machine-based model achieved a fairly good performance of 82.50% in precision and 88.89% in specificity. Conclusions To the best of our knowledge, our study is the first to apply the machine learning approach to predict the licensing outcomes for pharmaceutical patent valuation and technology transfer. Our work is a good alternative to the current patent valuation methods available in the market, and it could be
Journal of Pharmaceutical Innovation – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera